<DOC>
	<DOCNO>NCT02238470</DOCNO>
	<brief_summary>The purpose study determine whether Magnetic Resonance Imaging may predict risk Intracerebral Hemorrhage patient ischemic stroke receive indefinite oral anticoagulation</brief_summary>
	<brief_title>Intracerebral Hemorrhage Due Oral Anticoagulants : Prediction Risk Magnetic Resonance</brief_title>
	<detailed_description>OBJECTIVES . To evaluate whether Magnetic Resonance ( MR ) help predict risk Intracranial Hemorrhage ( ICH-OA ) patient ischemic stroke receive Oral Anticoagulants ( OA ) secondary prevention stroke . By allow detection quantification leukoaraiosis microbleeding , MR aid assessment hypertensive and/or amyloid angiopathy , two finding may increase risk ICH-OA . The study know variable associate risk ICH-OA improve selection patient treat OA . METHODOLOGY . A prospective , observational , multicentric study 1000 patient stroke , old 65 , candidate receive OA indefinitely . The primary end-point ICH-OA . A MR perform start treatment , evaluate presence degree leukoaraiosis ( Fazekas 's scale ) microbleeding ( BOMBS scale ) . A visit schedule first month inclusion , thereafter patient followed-up 2 year phone interview , evaluate appearance primary end-point . We register data demographic , vascular risk factor , anticoagulation , MR , echocardiography co-morbidity . With variable associate ICH-OA univariate analysis , regression analysis perform , ICH-OA dependent variable . Finally , independent predictive variable receive score elaborate predictive model ICH-OA .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Leukoaraiosis</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>1 . Age &gt; 65 2 . TIA ischemic stroke 3 . The patient receive indefinitely treatment oral anticoagulant secondary prevention cardioembolic stroke 4 . No previous treatment oral anticoagulant 5 . Signed consent perform Magnetic Resonance 6 . Longterm followup possible 1 . The patient receive oral anticoagulation primary prevention treatment 2 . The etiology motivate onset oral anticoagulant cardioembolism 3 . Absolute contraindication receive oral anticoagulant 4 . Arterial hypertension control , hypertensive crisis 5 . Dementia 6 . Liveexpectancy le 1 year 7 . Any social psychological reason prevents followup 8 . Contraindication perform Magnetic Resonance examination 9 . Patients receive oral antiacoagulants prior current stroke 10 . The Magnetic Resonance imaging perform 1 month onset treatment oral anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Ischemic stroke</keyword>
	<keyword>Intracerebral hemorrhage</keyword>
	<keyword>Subdural hemorrhage</keyword>
	<keyword>Microbleed</keyword>
	<keyword>Leukoaraiosis</keyword>
	<keyword>Oral anticoagulant</keyword>
</DOC>